Visiongain publishes BRIC Breast Pump Market Report 2020-2030

04 May 2020
Pharma

Visiongain has launched a new pharma report BRIC Breast Pump Market Report 2020-2030: Forecasts by Product (Open System, Closed System), Technology (Manual, Battery Powered, Electric), Application (Personal Use, Hospital Grade), and Geography (Brazil, Russia, India, China).

The BRIC breast pumps market is projected to grow on account of growing consumer awareness coupled with growing women employment rates in emerging economies. The BRIC breast pumps market is projected to grow at a lucrative CAGR of ~xyz% and anticipated to surpass USD xyz million by 2020.

To access the data contained in this document please email contactus@visiongain.com

Breast pumps are defined as medical devices used to extract milk from the mothers’ breasts. These devices are mostly used by women to continue to breastfeed their babies while they are still at the workplace. In some cases, physicians also suggest using breast pumps to enhance the supply of milk when the baby is unable to suck milk. For working women, breast pumps have emerged as an appropriate choice. Also, over the forecast period, it is anticipated that the BRIC breast pumps market will witness a lucrative growth opportunity owing to advancements in technology, for instance, double breast pumps help in eliminating fat from milk and also replaces it with higher caloric value.

Also, the advantages and value of breastfeeding are becoming increasingly among mothers. Despite growth in literacy rates, people are now willing to incorporate advanced medical technology in their daily lives. This is largely due to increased knowledge and disposable income, as well as the availability of the latest gadgets due to the penetration of key players on the market.

Over the forecast period, electric breast pumps are anticipated to experience the highest growth and are anticipated to continue its dominance owing to the growing tendency towards the usage of advanced products. Electric breast pumps are operated by a motor that fits over the nipple and sucks milk through plastic tubing. It allows effective suction, makes the pumping process significantly faster & easier as it allows the pumping of both breasts simultaneously.

Sometimes, electric pumps can be quite noisy & heavy, however, manufacturers are investing in R&D to tackle this challenge. Various companies also provide electric pumps on a rent basis as few mothers are unable to purchase these devices due to budget constraints. Some of the major players in this segment are Ameda AG and Philips AVENT. The recent advancement in technology has resulted in the launch of portable devices such as Ameda's Platinum Electric Breast Pump and Medela's Electric Swing Breast Pumps, which are anticipated to boost the market further.

Due to increased government investment in the healthcare sector and increased healthcare spending in the region, the BRIC breast pumps market is expected to grow with lucrative growth rates. Another factor driving its growth is the rising attention of prominent players across India and the Chinese breast pumps market. Also, emerging countries like India and China are anticipated to offer lucrative revenue generation avenues for market players over the forecast period.

Currently, key players are forming various strategies such as acquisitions, mergers, partnerships, collaborations, and launching new products to strengthen their position in the market. Companies are also expanding their R&D, distribution, and management facilities to expand their business and to hold a competitive edge in the BRIC Breast Pump Market.

The comprehensive market report features companies such as Ameda, Artsana S.p.A., ARDO, Koninklijke Philips N.V., Medela LLC, Mayborn Group Limited, Newell Brands, Pigeon Corporation, Bailey Medical, Hygeia II Medical Group Inc.among other prominent players. Also, the research study offers market estimation and forecast for the period ranging from 2020-2030 for markets such as Brazil, Russia, India, and China.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 20 7549 9987.

About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

Visiongain Publishes Healthcare Cold Chain Logistics Market Report 2020-2030

. The growth of this market is majorly driven by increasing sales of temperature sensitive pharmaceutical products, longer life expectancy and rising geriatric population are some of the prominent factors.

16 September 2020

Read

Visiongain Publishes Vaccines Sales Market Report 2020-2030

Visiongain forecasts a continuing growth in global market, submarket and product sales as human vaccines drive pharmaceutical business sales. New key players and technological progress will enter the industry, leading to an increase in the market size of the world market for human vaccines in general.

14 September 2020

Read

Visiongain Publishes Ophthalmic Ultrasound Systems Market Report 2020-2030

The global ophthalmic ultrasound systems market is driven by factors such as the increasing prevalence of ocular disorders and diseases, adoption of novel ophthalmic technologies, rising focus on research & development, and growing health awareness amongst the population.

09 September 2020

Read

Visiongain Publishes Drug Discovery Outsourcing Market Report 2020-2030

The current COVID-19 pandemic is anticipated to have a minor impact on the overall outsourcing business outlook for global drug discovery. Also, significant growth during the COVID-19 pandemic is expected to be seen in the outsourcing of drugs and medicines needed to treat COVID-19 infections.

07 September 2020

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever